Skip to main content
Premium Trial:

Request an Annual Quote

Genetic Association Information Network to Use Affy's SNP 6.0 Arrays

NEW YORK (GenomeWeb News) - The Genetic Association Information Network, a public and private partnership, will use Affymetrix's Genome-Wide Human SNP Array 6.0 in genomic studies of schizophrenia and bipolar disorder, Affy said today.
 
GAIN is run by the Foundation for the National Institutes of Health, the National Institutes of Health, and Pfizer Global Research and Development.
 
Affy said GAIN scientists will use the Human SNP 6.0 to analyze eight thousand samples from various ethnicities.
 
The company also said the GAIN program will provide information it collects to researchers worldwide through the National Center for Biotechnology Information’s database of Genotype and Phenotype, or dbGaP.
 
Financial terms of the agreement were not released.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.